Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain  Philippe Poulain, MD,

Similar presentations


Presentation on theme: "Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain  Philippe Poulain, MD,"— Presentation transcript:

1 Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain  Philippe Poulain, MD, Willy Denier, MD, Joep Douma, MD, Klaus Hoerauf, MD, PhD, Mirko Šamija, MD, Maciej Sopata, MD, Gernot Wolfram, MD  Journal of Pain and Symptom Management  Volume 36, Issue 2, Pages (August 2008) DOI: /j.jpainsymman Copyright © 2008 U.S. Cancer Pain Relief Committee Terms and Conditions

2 Fig. 1 Patient flow chart. aMultiple reasons for discontinuation of study could be mentioned. Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2008 U.S. Cancer Pain Relief Committee Terms and Conditions

3 Fig. 2 Mean daily pain intensity (a) and mean intake of rescue medication (b) during the run-in phase and maintenance phase. NRS pain scores and consumption of rescue medication are given as mean+95% confidence intervals. Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2008 U.S. Cancer Pain Relief Committee Terms and Conditions


Download ppt "Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain  Philippe Poulain, MD,"

Similar presentations


Ads by Google